Two-Stage Carcinogenesis and the Carcinogenicity of Phorbol Myristate Acetate (PMA)

1. Berenblum, I. (1941). The cocarcinogenic action of croton resin. Cancer Res. 1, 44–48.

2. Hecker, E. , and Bresch, H. (1965). Uber die wirkstoffe des crotonöls. Iii. Reindarstellung und characterisierung eines toxisch, entsündlich und cocarcinogen hochaktiven wirkstoffes. Zeits. Naturforsch. 206, 216–226.

3. Van Duuren, B.L. , and Orris, L. (1965). The tumor-enhancing principles of Croton tiglium L. Cancer Res. 25, 1871–1875.

4. Roe, F.J.C. (1989). Animal tests for carcinogenesis: Relevance for man. J. Am. Coll. Toxicol. 8, 1241–1246.

5. Iversen, O.H. , and Astrup, E.G. (1984). The paradigm of two-stage carcinogenesis: a critical attitude. Cancer Invest. 2, 51–60.

6. Iversen, O.H. (1988). Initiation, promotion: critical remarks on the two-stage theory. In: Iversen, O.H. (ed.). Theories of Carcinogenesis. Washington, DC: Hemisphere Publishing Company, pp. 119–126.

7. Van Duuren, B.L. (1969). Tumor-promoting agents in two-stage carcinogenesis. In: Homburger, F. , (ed.). Progress in Experimental Tumor Research. Basel: S. Karger, pp. 31–68.

8. Van Duuren, B.L. , Sivak, A. , Katz, C. , Seidman, I. , and Melchionne, S. (1975). The Effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res. 35, 502–505.

9. Van Duuren, B.L. , Sivak, A. , Segal, A. , Seidman, I. , and Katz, C. (1973). Dose-response studies with a pure tumor-promoting agent, phorbol myristate acetate. Cancer Res. 33, 2166–2172.

10. Van Duuren, B.L. , Langseth, L. , Sivak, A. , and Orris, L. (1966). The tumor-enhancing principles of Croton tiglium L. Ii. A comparative study. Cancer Res. 26, 1729–1733.